Chengdu Sino-strong Pharmaceutical Co., Ltd.
As of 20 November 2026, for the company name Chengdu Sino-strong Pharmaceutical Co., Ltd. as recorded, 1 application with this name as first applicant is listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 5 records, across 5 drug names; since 24 August 2026, the records list Marketing application approved: 1 application; the chemical-drug catalogue lists 3 active records with this name as holder; 39 active API registrations list this name as first registered company; 1 further acceptance record names it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.
Drug filings
5 acceptance records as first applicant, grouped into 5 source drug names. Source data as of 2026/11/20.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
布美他尼片 · No verified English name 1 records · Latest accepted 2025/09/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503490 | Generic | 2025/09/23 | Chengdu Sino-strong Pharmaceutical Co., Ltd.; Sichuan Sai Zhuo Pharma Co., Ltd. romanized | CDE ↗ |
碘解磷定注射液 · No verified English name 1 records · Latest accepted 2025/03/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501036 | Generic | 2025/03/13 | Chengdu Sino-strong Pharmaceutical Co., Ltd. | CDE ↗ |
Calcium Folinate Injection 1 records · Latest accepted 2024/07/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402177 | Generic | 2024/07/16 | Chengdu Sino-strong Pharmaceutical Co., Ltd. | CDE ↗ |
Sodium Nitroprusside Injection 1 records · Latest accepted 2023/06/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301634 | Generic | 2023/06/15 | Chengdu Sino-strong Pharmaceutical Co., Ltd. | CDE ↗ |
Levosimendan Injection 1 records · Latest accepted 2023/02/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300314 | Generic | 2023/02/03 | Chengdu Sino-strong Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
1 events from 2026/08/24 to 2026/11/21. CDE data as of 2026/11/20; NMPA data as of 2026/11/20.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 1 application
- 2026/11/03Marketing application approved
碘解磷定注射液 · No verified English name
CYHS2501036 · 国药准字H20266427
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 39 ↗
Under review
1 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 布美他尼片 · No verified English name | CYHS2503490 | Generic | 2025/09/23 | Chengdu Sino-strong Pharmaceutical Co., Ltd.; Sichuan Sai Zhuo Pharma Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
3 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | NMPA approval no. | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Calcium Folinate Injection | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Chengdu Sino-strong Pharmaceutical Co., Ltd. | 国药准字H20256243 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Nitroprusside Injection | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Chengdu Sino-strong Pharmaceutical Co., Ltd. | 国药准字H20249215 | 2024/10/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levosimendan Injection | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Chengdu Sino-strong Pharmaceutical Co., Ltd. | 国药准字H20243485 | 2024/04/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
39 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 蔗糖铁 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000638 | I | 2025/07/03 | CDE ↗ |
| 氯化锌 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000157 | A | 2026/10/14 | CDE ↗ |
| 氯化铁 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000137 | A | 2026/09/14 | CDE ↗ |
| 氯化铜 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000116 | A | 2026/08/13 | CDE ↗ |
| 亚硒酸钠 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000064 | A | 2026/08/28 | CDE ↗ |
| 钼酸钠 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000063 | A | 2026/07/20 | CDE ↗ |
| 氯化铬 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000115 | A | 2026/09/07 | CDE ↗ |
| 盐酸维拉帕米 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000050 | A | 2026/06/24 | CDE ↗ |
| 氟化钠 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20250000022 | A | 2026/07/21 | CDE ↗ |
| 氯化锰 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20240001518 | A | 2026/06/30 | CDE ↗ |
| 盐酸甲氧氯普胺 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20240000636 | A | 2026/02/27 | CDE ↗ |
| 盐酸氯普鲁卡因 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20240000390 | A | 2025/11/28 | CDE ↗ |
| 氯化琥珀胆碱 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20240000041 | A | 2026/09/12 | CDE ↗ |
| 氯解磷定 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20230001171 | A | 2025/09/11 | CDE ↗ |
| 碘解磷定 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20230000961 | A | 2025/12/13 | CDE ↗ |
| 磷酸氢二钾 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20230000824 | A | 2026/01/22 | CDE ↗ |
| 磷酸二氢钾 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20230000823 | A | 2026/01/22 | CDE ↗ |
| 盐酸异丙肾上腺素 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20230000131 | A | 2026/01/22 | CDE ↗ |
| 布美他尼 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20220001296 | A | 2026/01/22 | CDE ↗ |
| 硝普钠 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20220001181 | A | 2025/12/20 | CDE ↗ |
| 肾上腺素 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20220001036 | A | 2025/11/14 | CDE ↗ |
| 盐酸多巴酚丁胺 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20220000884 | A | 2026/01/22 | CDE ↗ |
| 盐酸溴己新 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20220000708 | A | 2026/01/22 | CDE ↗ |
| 重酒石酸去甲肾上腺素 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20220000724 | A | 2026/01/22 | CDE ↗ |
| 甲磺酸酚妥拉明 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20210000888 | A | 2025/01/14 | CDE ↗ |
| 甲硫酸新斯的明 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20210000033 | A | 2024/01/17 | CDE ↗ |
| 重酒石酸间羟胺 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20200001021 | A | 2024/01/17 | CDE ↗ |
| 盐酸帕洛诺司琼 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20200000425 | A | 2026/07/27 | CDE ↗ |
| 盐酸法舒地尔 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20190006594 | A | 2026/09/21 | CDE ↗ |
| 甲磺酸多拉司琼 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20190006350 | A | — | CDE ↗ |
| 盐酸溴己新 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20180001038 | A | 2026/01/09 | CDE ↗ |
| 琥珀酸普芦卡必利 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170001313 | I | — | CDE ↗ |
| 格隆溴铵 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170001168 | A | 2023/04/21 | CDE ↗ |
| 左西孟旦 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170001128 | A | 2025/11/14 | CDE ↗ |
| 盐酸戊乙奎醚 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170000965 | A | 2024/08/03 | CDE ↗ |
| 帕瑞昔布钠 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170000934 | A | 2024/04/25 | CDE ↗ |
| 盐酸替罗非班 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170000721 | A | 2023/08/10 | CDE ↗ |
| 埃索美拉唑钠 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170000149 | A | 2022/09/30 | CDE ↗ |
| 罗库溴铵 · No verified English name | Chengdu Sino-strong Pharmaceutical Co., Ltd. | Y20170000033 | A | 2026/05/20 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
1 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Levosimendan Injection | CYHS2301615 | Generic | 2023/06/13 | Beijing Min Kang Bai Cao Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Sino-strong Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/20
- Chemical-drug catalogue
- Last successful update: 2026/11/20
- API registrations
- Last successful update: 2026/11/20
- NMPA drug delivery notices
- Last successful update: 2026/11/20
Loaded notices dated 2026-11-06 to 2026-11-20; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.